Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

In Reply: "Does Insert Type Affect Clinical and Functional Outcome in Total Knee Arthroplasty?".

Fransen BL, Hoozemans MJ, Keijser LC, van Lent ME, Verheyen CC, Burger BJ.

J Arthroplasty. 2016 Jul;31(7):1615-6. doi: 10.1016/j.arth.2015.12.037. Epub 2016 Feb 6. No abstract available.

PMID:
26860963
2.

Peer review comments on drug trials submitted to medical journals differ depending on sponsorship, results and acceptance: a retrospective cohort study.

van Lent M, IntHout J, Out HJ.

BMJ Open. 2015 Sep 30;5(9):e007961. doi: 10.1136/bmjopen-2015-007961. Review.

3.

Does Insert Type Affect Clinical and Functional Outcome in Total Knee Arthroplasty? A Randomised Controlled Clinical Trial With 5-Year Follow-Up.

Fransen BL, Hoozemans MJ, Keijser LC, van Lent ME, Verheyen CC, Burger BJ.

J Arthroplasty. 2015 Nov;30(11):1931-7. doi: 10.1016/j.arth.2015.05.018. Epub 2015 May 20.

PMID:
26096070
4.

Differences between information in registries and articles did not influence publication acceptance.

van Lent M, IntHout J, Out HJ.

J Clin Epidemiol. 2015 Sep;68(9):1059-67. doi: 10.1016/j.jclinepi.2014.11.019. Epub 2014 Nov 29.

5.
6.

Role of editorial and peer review processes in publication bias: analysis of drug trials submitted to eight medical journals.

van Lent M, Overbeke J, Out HJ.

PLoS One. 2014 Aug 12;9(8):e104846. doi: 10.1371/journal.pone.0104846. eCollection 2014.

7.

Effect of funding source on publication bias is not so clear cut.

van Lent M, Out HJ.

BMJ. 2013 Dec 23;347:f7582. doi: 10.1136/bmj.f7582. No abstract available.

PMID:
24366203
8.

Recommendations for a uniform assessment of publication bias related to funding source.

van Lent M, Overbeke J, Out HJ.

BMC Med Res Methodol. 2013 Sep 30;13:120. doi: 10.1186/1471-2288-13-120.

9.

Tackling conflicts of interest. Industry tie may be benchmark of quality.

van Lent M, Out HJ.

BMJ. 2011 Sep 6;343:d5607. doi: 10.1136/bmj.d5607. No abstract available.

PMID:
21896592
10.

Interactive narrative.

van Lent M.

IEEE Comput Graph Appl. 2006 May-Jun;26(3):20-1. No abstract available.

PMID:
16711213
11.

Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review.

Scholten AN, van Putten WL, Beerman H, Smit VT, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, De Winter KA, Lutgens LC, van Lent M, Creutzberg CL; PORTEC Study Group.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):834-8. Epub 2005 May 31.

PMID:
15927414
12.

Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial.

Creutzberg CL, van Putten WL, Wárlám-Rodenhuis CC, van den Bergh AC, de Winter KA, Koper PC, Lybeert ML, Slot A, Lutgens LC, Stenfert Kroese MC, Beerman H, van Lent M; postoperative Radiation Therapy in Endometrial Carcinoma Trial.

J Clin Oncol. 2004 Apr 1;22(7):1234-41.

PMID:
15051771
13.

Survival after relapse in patients with endometrial cancer: results from a randomized trial.

Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, van der Steen-Banasik E, Beerman H, van Lent M; PORTEC Study Group.

Gynecol Oncol. 2003 May;89(2):201-9.

PMID:
12713981
14.

The morbidity of treatment for patients with Stage I endometrial cancer: results from a randomized trial.

Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, van der Steen-Banasik E, Beerman H, van Lent M; PORTEC Study Group. The Postoperative Radiation Therapy in Endometrial Carcinoma.

Int J Radiat Oncol Biol Phys. 2001 Dec 1;51(5):1246-55.

PMID:
11728684
15.

Metastasectomy, a feasible treatment in selected cases with gynecologic malignancy.

Logmans A, ten Kate M, van Lent M.

Eur J Obstet Gynecol Reprod Biol. 2000 Aug;91(2):165-7.

PMID:
10869790
16.

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma.

Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, van de Steen-Banasik E, Beerman H, van Lent M.

Lancet. 2000 Apr 22;355(9213):1404-11.

PMID:
10791524
17.

Should doctors reconstruct the vaginal introitus of adolescent girls to mimic the virginal state? Who wants the procedure and why.

Logmans A, Verhoeff A, Raap RB, Creighton F, van Lent M.

BMJ. 1998 Feb 7;316(7129):459-60. No abstract available.

18.

High tissue factor concentration in the omentum, a possible cause of its hemostatic properties.

Logmans A, Schoenmakers CH, Haensel SM, Koolhoven I, Trimbos JB, van Lent M, van Ingen HE.

Eur J Clin Invest. 1996 Jan;26(1):82-3.

PMID:
8682161
19.

The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer.

van der Burg ME, van Lent M, Buyse M, Kobierska A, Colombo N, Favalli G, Lacave AJ, Nardi M, Renard J, Pecorelli S.

N Engl J Med. 1995 Mar 9;332(10):629-34.

20.

Results of decentralized in-vitro fertilization treatment with transport and satellite clinics.

Roest J, Verhoeff A, van Lent M, Huisman GJ, Zeilmaker GH.

Hum Reprod. 1995 Mar;10(3):563-7.

PMID:
7782432
21.

The omentoplasty: a neglected ally in gynecologic surgery.

Logmans A, Trimbos JB, van Lent M.

Eur J Obstet Gynecol Reprod Biol. 1995 Feb;58(2):167-71. Review.

PMID:
7774745
22.

The pedicled omentoplasty, a simple and effective surgical technique to acquire a safe pelvic radiation field; theoretical and practical aspects.

Logmans A, van Lent M, van Geel AN, Olofsen-Van Acht M, Koper PC, Wiggers T, Trimbos JB.

Radiother Oncol. 1994 Dec;33(3):269-71.

PMID:
7716269
23.

EMG profiles of ACL-deficient patients during walking: the influence of mild fatigue.

van Lent ME, Drost MR, vd Wildenberg FA.

Int J Sports Med. 1994 Nov;15(8):508-14.

PMID:
7890466
24.

Results of curettage for postmenopausal vaginal bleeding in women treated with tamoxifen and megestrol acetate for progressive metastatic breast carcinoma.

Logmans A, Mous HV, Bontenbal M, Beerman H, van Lent M.

Eur J Obstet Gynecol Reprod Biol. 1994 Sep;56(3):173-6. Review.

PMID:
7821489
25.

Ovarian cysts, cytology and histology: a conflicting story.

Sheombar ES, Logmans A, Verhoeff A, van Lent M.

Eur J Obstet Gynecol Reprod Biol. 1993 Nov;52(1):41-4.

PMID:
8119473
26.

Watch and wait after careful surgical treatment and staging in well-differentiated early ovarian cancer.

Trimbos JB, Schueler JA, van der Burg M, Hermans J, van Lent M, Heintz AP, Fleuren GJ.

Cancer. 1991 Feb 1;67(3):597-602.

PMID:
1985754
27.

Long-term survival in ovarian cancer. Mature data from The Netherlands Joint Study Group for Ovarian Cancer.

Neijt JP, ten Bokkel Huinink WW, van der Burg ME, van Oosterom AT, Willemse PH, Vermorken JB, van Lindert AC, Heintz AP, Aartsen E, van Lent M, et al.

Eur J Cancer. 1991;27(11):1367-72.

PMID:
1835850
28.

Carboplatin and cyclophosphamide salvage therapy for ovarian cancer patients relapsing after cisplatin combination chemotherapy.

van der Burg ME, Hoff AM, van Lent M, Rodenburg CJ, van Putten WL, Stoter G.

Eur J Cancer. 1991;27(3):248-50.

PMID:
1827305
29.

Malignant leiomyomatosis peritonealis disseminata.

Akkersdijk GJ, Flu PK, Giard RW, van Lent M, Wallenburg HC.

Am J Obstet Gynecol. 1990 Aug;163(2):591-3.

PMID:
2386147
30.

Reasons for incomplete surgical staging in early ovarian carcinoma.

Trimbos JB, Schueler JA, van Lent M, Hermans J, Fleuren GJ.

Gynecol Oncol. 1990 Jun;37(3):374-7.

PMID:
2351322
31.

Randomized trial comparing two combination chemotherapy regimens (CHAP-5 v CP) in advanced ovarian carcinoma.

Neijt JP, ten Bokkel Huinink WW, van der Burg ME, van Oosterom AT, Willemse PH, Heintz AP, van Lent M, Trimbos JB, Bouma J, Vermorken JB, et al.

J Clin Oncol. 1987 Aug;5(8):1157-68.

PMID:
3114434
32.

Cytoreductive surgery with or without preceding chemotherapy in ovarian cancer.

Neijt JP, Aartsen EJ, Bouma J, Heintz AP, van Lent M, van Lindert AC.

Prog Clin Biol Res. 1985;201:217-23. No abstract available.

PMID:
4095113
33.

Randomised trial comparing two combination chemotherapy regimens (Hexa-CAF vs CHAP-5) in advanced ovarian carcinoma.

Neijt JP, ten Bokkel Huinink WW, van der Burg ME, van Oosterom AT, Vriesendorp R, Kooyman CD, van Lindert AC, Hamerlynck JV, van Lent M, van Houwelingen JC, et al.

Lancet. 1984 Sep 15;2(8403):594-600.

PMID:
6147640
34.

Cryosurgical treatment of cervical intraepithelial neoplasia (CIN III) in 102 patients.

van Lent M, Trimbos JB, Heintz AP, van Hall EV.

Gynecol Oncol. 1983 Oct;16(2):240-5.

PMID:
6629125
35.

[Cryosurgery as conservative treatment of patients with premalignant lesions of the uterine cervix].

Trimbos JB, van Lent M.

Ned Tijdschr Geneeskd. 1982 Nov 13;126(46):2100-3. Dutch. No abstract available.

PMID:
7177216
36.

Choriocarcinoma in mother and child, identified by immunoenzyme histochemistry.

Kruseman AC, van Lent M, Blom AH, Lauw GP.

Am J Clin Pathol. 1977 Mar;67(3):279-83.

PMID:
320862

Supplemental Content

Loading ...
Support Center